Should I buy Ryan Specialty (RYAN) stock or is it too late?

Ryan Specialty · Financials · price $44

See the full Ryan Specialty (RYAN) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Mizuho — 82% of its targets hit on this sector (28 calls tested). It aims for $48 (+10 %), call made on August 1, 2026, maturing on August 1, 2027 (27 d ago).

The 10 reliable analysts $48+10 %

The 3 other firms $50+15 %

How to read it: the 10 reliable firms are not filtered by optimism — 9 aim above the price, 1 below, hence their $48 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Ryan Specialty

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Wells Fargo	100 %	+25.5 %	6	$43 -1%
UBS	40 %	-1.2 %	5	$55 +26%
Barclays	43 %	-2.2 %	7	$48 +10%
Keefe, Bruyette & Woods	50 %	-3.3 %	6	$54 +24%
JP Morgan	20 %	-18.0 %	5	$45 +3%
Morgan Stanley	0 %	-37.2 %	6	$50 +15%

In short — Should you invest in Ryan Specialty? Is it too late, still worth it? Analysts are split (54% buy, median target $48, i.e. +10%), and the most reliable on RYAN targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $48, i.e. +10% from the current price ($44).
The most reliable firm on RYAN, RBC Capital (100% hit rate, 2 scored calls), targets $55 (call made on July 31, 2026, maturing on July 31, 2027) (+26%) in its most recent call.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 13 ratings, 5 are neutral and 1 is a sell.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on RYAN

Median target $48 (+10%) · 13 ratings · Hold consensus

Strong Buy00%

Buy754%

Hold538%

Sell18%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Ryan Specialty now?

We won't decide for you. The facts: 54% of analysts rate it a buy, median target $48 (+10%), and RBC Capital (most reliable on RYAN, 100%) targets $55. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Ryan Specialty?

Not according to analysts: the median target ($48) is still +10% above the current price ($44) (most reliable on RYAN: RBC Capital, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Ryan Specialty still worth investing in?

It depends on the gap between the price ($44) and its estimated value: analysts target $48 on median (+10%), with 54% buys (most reliable on RYAN: RBC Capital, 100%). Cross-check with their real reliability on RYAN and the cautions above. Information, not advice.

What's the main risk in buying RYAN?

The consensus is not unanimous: of 13 ratings, 5 are neutral and 1 is a sell.

→ Go deeper: the full Ryan Specialty profile (consensus, analyst reliability, price target, performance).